Previously, PGC‐1α has been shown as a promising candidate to ameliorate aging‐related musculoskeletal deterioration, cardiomyopathy, and postoperative delirium (Kang & Li Ji, 2012; Zhou et al., 2023; Zhu et al., 2019). The gene discussed is PPARGC1A; the disease is cardiomyopathy.